Search Results - "Samalin, Emmanuelle"

Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance by Pernot, Simon, Terme, Magali, Radosevic-Robin, Nina, Castan, Florence, Badoual, Cécile, Marcheteau, Elie, Penault-Llorca, Fréderique, Bouche, Olivier, Bennouna, Jaafar, Francois, Eric, Ghiringhelli, Francois, De La Fouchardiere, Christelle, Samalin, Emmanuelle, Baptiste Bachet, Jean, Borg, Christophe, Boige, Valérie, Voron, Thibault, Stanbury, Trevor, Tartour, Eric, Gourgou, Sophie, Malka, David, Taieb, Julien

“…Background The correlation between immune cells and the Lauren classification subtypes and their prognostic impact in advanced gastric cancer (AGC) are…”
Get full text

FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell by Relier, Sébastien, Ripoll, Julie, Guillorit, Hélène, Amalric, Amandine, Achour, Cyrinne, Boissière, Florence, Vialaret, Jérôme, Attina, Aurore, Debart, Françoise, Choquet, Armelle, Macari, Françoise, Marchand, Virginie, Motorin, Yuri, Samalin, Emmanuelle, Vasseur, Jean-Jacques, Pannequin, Julie, Aguilo, Francesca, Lopez-Crapez, Evelyne, Hirtz, Christophe, Rivals, Eric, Bastide, Amandine, David, Alexandre

“…Cancer stem cells (CSCs) are a small but critical cell population for cancer biology since they display inherent resistance to standard therapies and give rise…”
Get full text

Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial by Bernard-Tessier, Alice, Jeannot, Emmanuelle, Guenat, David, Debernardi, Alice, Michel, Marc, Proudhon, Charlotte, Vincent-Salomon, Anne, Bièche, Ivan, Pierga, Jean-Yves, Buecher, Bruno, Meurisse, Aurélia, François, Éric, Cohen, Romain, Jary, Marine, Vendrely, Véronique, Samalin, Emmanuelle, El Hajbi, Farid, Baba-Hamed, Nabil, Borg, Christophe, Bidard, François-Clément, Kim, Stefano

“…Human papillomavirus (HPV) is found in 90% of squamous cell carcinomas of the anal canal (SCCA). We investigated the clinical validity of HPV circulating tumor…”
Get full text

Therapeutic Bayesian monitoring of sunitinib in two patients with impaired absorption or elimination by Leenhardt, Fanny, Viala, Marie, Tosi, Diego, Samalin‐Scalzi, Emmanuelle, Evrard, Alexandre, Mbatchi, Litaty C.

“…What is known and Objective Sunitinib pharmacokinetics can be influenced by the physio‐pathological conditions of individual patients. Therapeutic drug…”
Get full text

The Role of the FOLFIRINOX Regimen for Advanced Pancreatic Cancer by Conroy, Thierry, Gavoille, Céline, Samalin, Emmanuelle, Ychou, Marc, Ducreux, Michel

“…In 2010, the FOLFIRINOX regimen (bolus and infusional 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin) emerged as a new option in patients with…”
Get full text

Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial by Kim, Stefano, Buecher, Bruno, André, Thierry, Jary, Marine, Bidard, François-Clément, Ghiringhelli, François, François, Éric, Taieb, Julien, Smith, Denis, de la Fouchardière, Christelle, Desramé, Jérôme, Samalin, Emmanuelle, Parzy, Aurélie, Baba-Hamed, Nabil, Bouché, Olivier, Tougeron, David, Dahan, Laëtitia, El Hajbi, Farid, Jacquin, Marion, Rebucci-Peixoto, Magali, Spehner, Laurie, Vendrely, Véronique, Vernerey, Dewi, Borg, Christophe

“…Modified docetaxel, cisplatin, and 5-fluorouracil (mDCF) regimen has become a new standard for the treatment of metastatic or unresectable locally advanced…”
Get full text

Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial by Trouiller, Jean-Baptiste, Macabeo, Bérengère, Poll, Andrew, Howard, Dan, Buckland, Andy, Sivignon, Marine, Clay, Emilie, Malka, David, Samalin, Emmanuelle, Toumi, Mondher, Laramée, Philippe

“…ObjectiveThe BEACON CRC randomised controlled trial (NCT02928224) in BRAF-mutant metastatic colorectal cancer (mCRC) patients showed improved overall survival…”
Get full text

The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program by Aparicio, Thomas, Cozic, Nathalie, de la Fouchardière, Christelle, Meriaux, Emeline, Plaza, Jérome, Mineur, Laurent, Guimbaud, Rosine, Samalin, Emmanuelle, Mary, Florence, Lecomte, Thierry, Gomez-Roca, Carlos, Haineaux, Paul-Arthur, Gratet, Alain, Selves, Jannick, Menu, Yves, Colignon, Nikias, Johnson, Laetitia, Legrand, Frédéric, Vassal, Gilles

“…Background The AcSé-crizotinib program provides extensive screening of crizotinib-targeted genomic alteration in several malignancies. We here report the…”
Get full text

Characteristics of BRAFV600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients by Fouchardière, Christelle, Cohen, Romain, Malka, David, Guimbaud, Rosine, Bourien, Héloïse, Lièvre, Astrid, Cacheux, Wulfran, Artru, Pascal, François, Eric, Gilabert, Marine, Samalin‐Scalzi, Emmanuelle, Zaanan, Aziz, Hautefeuille, Vincent, Rousseau, Benoit, Senellart, Hélène, Coriat, Romain, Flippot, Ronan, Desseigne, Françoise, Lardy‐Cleaud, Audrey, Tougeron, David

“…Background BRAFV600E mutations occurring in about 10% of metastatic colorectal cancers (mCRCs) are usually associated with a poor outcome. However, their…”
Get full text

Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study) by Kim, Stefano, Jary, Marine, André, Thierry, Vendrely, Véronique, Buecher, Bruno, François, Eric, Bidard, François-Clément, Dumont, Sarah, Samalin, Emmanuelle, Peiffert, Didier, Pernot, Simon, Baba-Hamed, Nabil, El Hajbi, Farid, Bouché, Olivier, Desrame, Jérôme, Parzy, Aurélie, Zoubir, Mustapha, Louvet, Christophe, Bachet, Jean-Baptiste, Nguyen, Thierry, Abdelghani, Meher Ben, Smith, Denis, De La Fouchardière, Christelle, Aparicio, Thomas, Bennouna, Jaafar, Gornet, Jean-Marc, Jacquin, Marion, Bonnetain, Franck, Borg, Christophe

“…The squamous cell carcinoma of the anus (SCCA) is a rare disease, but its incidence is markedly increasing. About 15% of patients are diagnosed at metastatic…”
Get full text

Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma by Kim, Stefano, Meurisse, Aurélia, Spehner, Laurie, Stouvenot, Morgane, François, Eric, Buecher, Bruno, André, Thierry, Samalin, Emmanuelle, Jary, Marine, Nguyen, Thierry, El Hajbi, Farid, Baba-Hamed, Nabil, Pernot, Simon, Kaminsky, Marie-Christine, Bouché, Olivier, Desrame, Jerome, Zoubir, Mustapha, Ghiringhelli, François, Parzy, Aurélie, de la Fouchardiere, Christelle, Boulbair, Fatiha, Lakkis, Zaher, Klajer, Elodie, Jacquin, Marion, Taieb, Julien, Vendrely, Véronique, Vernerey, Dewi, Borg, Christophe

“…Aims: The addition of docetaxel to cisplatin and 5-fluorouracil (DCF) has shown promising efficacy in advanced squamous cell carcinoma of the anus (SCCA)…”
Get full text

DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study by Kim, Stefano, Vendrely, Véronique, Saint, Angélique, André, Thierry, Vaflard, Pauline, Samalin, Emmanuelle, Pernot, Simon, Bouché, Oliver, Zubir, Mustapha, Desrame, Jérôme, de la Fouchardière, Christelle, Smith, Denis, Ghiringhelli, François, Vienot, Angélique, Jacquin, Marion, Klajer, Elodie, Nguyen, Thierry, François, Éric, Taieb, Julien, Le Malicot, Karine, Vernerey, Dewi, Meurisse, Aurélia, Borg, Christophe

“…Triplet DCF (docetaxel, cisplatin and 5-flurouracil) and doublet CP/CF (carboplatin and paclitaxel/cisplatin and 5-fluorouracil) regimens were prospectively…”
Get full text

Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort by Pernot, Simon, Mitry, Emmanuel, Samalin, Emmanuelle, Dahan, Laetitia, Dalban, Cécile, Ychou, Marc, Seitz, Jean-François, Turki, Hajer, Mazard, Thibault, Zaanan, Aziz, Lepère, Céline, Vaillant, Jean-Nicolas, Landi, Bruno, Rougier, Philippe, Taieb, Julien

“…Background Docetaxel–cisplatin-5-FU chemotherapy is superior to 5-FU-cisplatin in terms of response rate and survival in advanced gastric cancer (AGC), but is…”
Get full text

Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study by Lièvre, Astrid, Samalin, Emmanuelle, Mitry, Emmanuel, Assenat, Eric, Boyer-Gestin, Christine, Lepère, Céline, Bachet, Jean-Baptiste, Portales, Fabienne, Vaillant, Jean-Nicolas, Ychou, Marc, Rougier, Philippe

“…The anti-VEGF antibody bevacizumab associated with an irinotecan or oxaliplatin-based chemotherapy was proved to be superior to the chemotherapy alone in first…”
Get full text

Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancer by Altwegg, Romain, Ychou, Marc, Guillaumon, Vanessa, Thezenas, Simon, Senesse, Pierre, Flori, Nicolas, Mazard, Thibault, Caillo, Ludovic, Faure, Stéphanie, Samalin, Emmanuelle, Assenat, Eric

“…AIM： To investigate second-line chemotherapy in gemcitabine-pretreated patients with advanced or metastat- ic pancreatic cancer [（frequency, response, outcome,…”
Get full text

TAS-118 plus oxaliplatin in advanced gastric cancer: is it worth it? by Samalin, Emmanuelle, Adenis, Antoine

“…Globally, doublet or triplet chemotherapy regimens with a platinum-fluoropyrimidine backbone are the preferred first-line treatment for fit patients with…”
Get full text

Colonic Flat Neoplasia: Frequency and Concordance Between Endoscopic Appearance and Histological Diagnosis in a French Prospective Series by DIEBOLD, Marie-Danièle, SAMALIN, Emmanuelle, CADIOT, Guillaume, MERLE, Corinne, BOUCHE, Olivier, HIGUERO, Thierry, JOLLY, Damien, RAMAHOLIMIHASO, Fidy, RENARD, Pascal, YAZIJI, Nahla, THIEFIN, Gérard

Get full text

Treatment of gastric adenocarcinoma: A rapidly evolving landscape by Taieb, Julien, Bennouna, Jaafar, Penault-Llorca, Frederique, Basile, Debora, Samalin, Emmanuelle, Zaanan, Aziz

“…Gastric adenocarcinoma (GC) and gastroesophageal junction adenocarcinoma represent frequent and severe diseases whose management has radically changed over the…”
Get full text

Neoadjuvant therapy for gastroesophageal adenocarcinoma by Samalin, Emmanuelle, Ychou, Marc

“…Gastric and esophageal adenocarcinomas are one of the main causes of cancer-related death worldwide. While the incidence of gastric adenocarcinoma is…”
Get full text

New drug approval: Encorafenib-metastatic colorectal cancers with BRAF V600E mutation after systemic chemotherapy by Boilève, Alice, Samalin, Emmanuelle

Get more information